A Research Registry on Aggressive PitNETs
This research is collecting details about a type of brain tumour called an aggressive pituitary tumour. These tumours are rare, so doctors are keen to gather as much information as possible to understand them better. A group of highly experienced doctors in France, called HYPOcare, regularly discuss cases of patients with these tumours. This study will use the information from these expert discussions to create a large dataset for research. This will help scientists look for patterns and 'markers' that could lead to new ways to diagnose and treat these tumours, ultimately aiming to improve care for patients in the future.
At a glance
What is this study about?
This research project is designed to gather important information about a specific type of brain tumour called an "aggressive pituitary tumour." The pituitary gland is a tiny gland at the base of your brain that controls many important body functions. Sometimes, tumours can grow there. An "aggressive" tumour means it might grow quickly or spread, making it more challenging to treat.
Because these aggressive pituitary tumours are quite rare, it's hard for doctors and scientists to learn enough about them from just a few cases. This study aims to bring together a lot of information from many patients to create a big picture. The goal is to help researchers find specific signs or 'markers' related to these tumours. Understanding these markers could open doors to better ways of diagnosing, monitoring, and treating them.
In France, there's a special meeting of experts called HYPOcare. They focus solely on aggressive pituitary tumours and other related conditions. They regularly discuss individual patient cases to decide on the best treatment plans. This study will use the anonymised information already discussed in these expert meetings to build a large research database. This is important because, until now, this valuable information was only used for direct patient care, not for wider research.
Key takeaways
- This study helps understand rare, aggressive pituitary tumours.
- It uses existing medical information from expert discussions.
- No extra tests or appointments are needed for participants.
- The goal is to improve future treatments for patients.
- Your data will be anonymised to protect your privacy.
- You can choose not to participate at any time.
Who may be eligible?
To be part of this study, you would need to have been diagnosed with a pituitary tumour. Also, your specific medical case must have already been discussed by the national group of experts in France called HYPOcare, which focuses on aggressive pituitary tumours.
This study is for adults aged 18 and over, and both men and women can take part. There's no upper age limit.
You would not be included in this study if you clearly tell the researchers that you do not want your information to be used for this research.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do you have a diagnosis of a pituitary tumour?
- Has your case been discussed by the HYPOcare expert group in France?
- Are you 18 years old or older?
- Have you not objected to your medical information being used for research purposes?
What does participation involve?
Taking part in this study would involve your existing medical information, which has already been discussed by the HYPOcare expert group, being used for research purposes. This means that details from your medical file, already collected as part of your normal care, would be added to a larger database for scientists to study.
You would not need to attend any extra appointments, take new medications, or undergo any additional tests specifically for this research. There are no follow-up visits required for the study itself, beyond your standard medical care. Your participation essentially involves allowing your anonymised medical data to contribute to a wider understanding of aggressive pituitary tumours.
Potential risks and benefits
Locations (1)
- Hospices Civils de Lyon - Groupement Hospitalier EstVerified postcodeLyon, France· Recruiting
Common questions
What is an 'aggressive pituitary tumour'?
It's a type of growth on your pituitary gland (a small gland in your brain) that tends to grow more quickly or behave in a more challenging way than other pituitary tumours.
What is the HYPOcare meeting?
It's a meeting in France where a team of experts discuss difficult cases of aggressive pituitary tumours to decide on the best treatment for patients.
Will I have to do anything extra if I join this study?
No, you won't need any extra appointments, tests, or medication. The study uses information already collected during your usual medical care.
Will my personal details be safe?
Yes, the information used in research registries like this is anonymised, meaning your name and other identifying details are removed to protect your privacy.
Can I decide not to be part of this research?
Yes, absolutely. You have the right to object to your information being used for this research at any point.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.